CUPR - Cuprina Holdings Ltd Analyst Consensus Forecast

Brandmark of Cuprina Holdings Ltd (CUPR)

Cuprina Holdings (Cayman) Ltd (CUPR) is a Singapore-based biotech firm that attracts experts through the significance of its developments and an ethical approach to labor. The market dynamics reflected in the quotes, where the value is 0.00, underscore the stability of a business shielded from trade conflicts by the neutral status of its jurisdiction. Cuprina Holdings (Cayman) Ltd (CUPR) dominates a niche segment by utilizing living organisms for tissue regeneration, which outperforms the effectiveness of standard antibiotics in the therapy of chronic wounds.

cuprina.com.sg (CUPR) - Price Target Chart from 04/11/2025 to 11/15/2026

Metric breakdowns and analytics for Cuprina Holdings (Cayman) Ltd (CUPR)

- market price and analyst price targets:
General company analysis:CUPR - Cuprina Holdings
Brand item of Cuprina Holdings Limited

The fundamental attractiveness of the asset is determined by comparing the market price with the calculated business value based on the discounting of future cash flows. The current consolidated target for the security on GURU.Markets aggregates expert estimates, reflecting the valuation dynamics of Cuprina Holdings (CUPR) as it implements international management standards and commercializes medical developments, allowing investors to promptly track the transformation of market expectations.

Competing companies

HCA (HCA Healthcare) - Fair Value Consensus|Analyst Consensus Forecast THC (Tenet)|FMS - Consensus Target|SOLV - Price Target Chart|Encompass Health Corporation (EHC) - Consensus Target|UHS (uhsinc.com) - Consensus Target|DVA: Analyst Forecast Prices|Consensus Target RDNT|OPCH (Option Care Corp) - Analyst Forecast Prices|Price Target Chart Surgery Partners, Inc. (SGRY)|PINC (Premier, Inc.) - Fair Value Consensus|Analyst Consensus Forecast EYE (nationalvision.com)|Progyny (PGNY) - Average Forecast Price|Ardent Health - Analyst Consensus Forecast|Select Medical Inc. - Analyst Forecast Prices|ASTH (Apollo Medical Holdings) - Consensus Target|Average Forecast Price MEDNAX (MD)|Price Target Chart usph.com|Consensus Target The Pennant Group (PNTG)|Analyst Consensus Forecast ORGO|NUTX - Average Forecast Price|Price Target Chart Auna AUNA|Analyst Forecast Prices SBC (SBC Medical Group Holdings)|EOLS: Consensus Target|CHS (CYH) - Consensus Target|SKIN (beautyhealth.com) - Consensus Target|Consensus Target MediWound Ltd|BTMD (biote.com) - Analyst Consensus Forecast|JYNT: Fair Value Consensus|Analyst Consensus Forecast DCGO|Analyst Consensus Forecast P3 Health (PIII)|Price Target Chart Gain Therapeutics, Inc. GANX|Analyst Consensus Forecast EUDA Health EUDA|BMGL - Price Target Chart|Forecast Levels Chart CLGN|CCM: Analyst Consensus Forecast|American Shared Hospital Services Inc (AMS) - Analyst Consensus Forecast|Price Target Chart MEDIROM Corp|ALBT: Fair Value Consensus|Analyst Consensus Forecast DHAI|Analyst Forecast Prices XAGE|Analyst Consensus Forecast NIVF (NewGenIvf Group Limited)|Analyst Median Target ATI Physical Therapy Corp (ATIP)|CMAX - Price Target Chart|Fair Value Consensus KDLY (Kindly MD Corp)|MODV: Analyst Consensus Forecast|Novo Integrated Sciences - Fair Value Consensus|Consensus Target SSY|BACK - Analyst Target Range